Shares of Biocon Ltd. are witnessing volatile moves on Tuesday, October 7, after its wholly-owned subsidiary received tentative approval from the US Food and...
Drugmaker Zydus Lifesciences Ltd on Monday (October 6) said it has received final approval from the United States Food and Drug Administration (USFDA) for...
Lupin has bagged the approval for Lenalidomide capsules, the bioequivalent to Revlimid capsules manufactured by Bristol-Myers Squibb Company.This drug is used to treat...
Shares of Lupin Ltd. gained on Wednesday, September 3, said it has received approval from the United States Food and Drug Administration (USFDA) for...